Stock 002653 HAISCO PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Haisco Pharmaceutical Group Co., Ltd.

Equities

002653

CNE100001BC7

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
30.36 CNY +1.47% Intraday chart for Haisco Pharmaceutical Group Co., Ltd. +7.66% +31.14%
04-19 Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-18 Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Haisco Pharma Gets Nod to Trial Asthma Drug
Haisco Pharma Gets Nod to Trial HSK16149 Capsule as Central Neuropathic Pain Drug
Haisco Pharma's Unit Gets Nod to Trial Tumor Drug Candidate
Haisco Pharma to Set Up New Subsidiary in China’s Tibet Region
Haisco Pharmaceutical Signs $462 Million Deal with Italy’s Chiesi Farmaceutici
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Haisco Pharmaceutical Group Co., Ltd. Announces Management Changes
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Haisco Pharmaceutical's Unit Gets Greenlight to Trial Diabetes Drug
Haisco Pharma's Rupatadine Fumarate Tablets Passes Regulator's Evaluation
Haisco Pharma’s Blood Clot Drug Passes Generic Consistency Evaluation in China
Haisco Pharma Unit Gets Certification for Formula Food
Haisco Pharma Gets Nod for HSK31679 Tablet Trial
Haisco Pharma Unit Registers Nutritional Formula Food
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Haisco Pharma Unit Gets Certificate for Two Food Supplements
Haisco Pharmaceutical Wins Regulatory Nod to Trial Prostate Cancer Drug
Haisco Pharmaceutical Gets Nod for China Clinical Trial of Lung Cancer Drug; Shares Jump 3%
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002653 Stock
  4. News Haisco Pharmaceutical Group Co., Ltd.
  5. Other languages